Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Jan 1;44(1):58-61.
doi: 10.1097/DAD.0000000000001999.

A Case of Primary Myelofibrosis With Transformation to Leukemia Cutis

Affiliations
Case Reports

A Case of Primary Myelofibrosis With Transformation to Leukemia Cutis

Jasmine Saleh et al. Am J Dermatopathol. .

Abstract

We report an extraordinary case of primary myelofibrosis with transformation to leukemia cutis. A 64-year-old Caucasian man with a history of JAK2-positive primary myelofibrosis presented with erythematous papulonodules on his right lower extremity. A punch biopsy revealed a normal epidermis with an underlying diffuse dermal infiltrate composed of medium-to-large-sized myeloid cells and leukocytes. Neoplastic cells were immunoreactive for LCA, CD34, CD61, CD117, and CD68 and negative for lysozyme, CD20, CD3, myeloperoxidase, and TdT. These findings were consistent with a diagnosis of leukemia cutis. A concurrent bone marrow biopsy demonstrated a markedly fibrotic, hypercellular marrow without a significant increase in blasts. With no morphologic evidence of bone marrow involvement by acute myeloid leukemia, our case suggests that the patient's primary myelofibrosis transformed to leukemia cutis. Our patient died 2 months after the onset of his skin nodules. Our case demonstrates that leukemia cutis should be included in the differential diagnosis for cutaneous nodular lesions in patients with a history of an advanced-stage hematological malignancy.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

References

    1. “Primary Myelofibrosis”. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. Lyon, France: International Agency for Research on Cancer; 2017.
    1. Corella F, Barnadas MA, Bordes R, et al. A case of cutaneous extramedullary hematopoiesis associated with idiopathic myelofibrosis. Actas Dermosifilliogr. 2008;99:297–300.
    1. Collie AM, Uchin JM, Bergfeld WF, et al. Cutaneous intravascular extramedullary hematopoiesis in a patient with post-polycyhtemia vera myelofibrosis. J Cutan Pathol. 2013;40:615–620.
    1. Del Forno C, Borroni G, Caresana G, et al. Cutaneous extramedullary hematopoiesis in idiopathic myelofibrosis. Description of a case. G Ital Dermatol Venereol. 1990;125:205–209.
    1. Fernandez Acenero MJ, Borbuo J, Villanueva C, et al. Extramedullary hematopoiesis in an adult. J Am Acad Dermatol. 2003;48:S62–S63.

Publication types